That company subsequently expanded its business by acquiring many companies, including Unipath, Clondiag, Ionian Technologies, TwistDx, Wampole Laboratories, Ostex International, Binax, Biosite, HemoSense, Cholestech, Redwood Toxicology, Concateno, BBI Holdings, eScreen, Standard Diagnostics, and hhh Axis-Shield.

[7] In October 2014, the board of directors voted and instated Namal Nawana as the permanent CEO of Alere, Inc.

[10] With the acquisition of Alere, the company also obtain the subsidiary Arriva Medical, which is the largest mail-order diabetic supplier.

Alere operated three business units focused on cardiometabolic, infectious disease, and toxicology testing.

[2] The company was a pioneer in manufacturing rapid point-of-care diagnostic tests and provided products to healthcare professionals and patients worldwide.

[14] In 2016 the U.S. Justice Department launched an investigation into Alere's role in potential Medicaid and Medicare fraud.